Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

farrell90. You should write an article for SA. Some don't like them due to some negative hitpieces, but, the majority have been positive on IPIX.

Sadly, mine was the last one published on SA for IPIX and that was quite awhile back. Brilacidin for use against a virus was quite far from my mind.

https://seekingalpha.com/article/4088788-innovation-pharmaceuticals-stock-may-be-triple-crown-winner-brilacidin-year-end?source=content_type:react|section:All|sectionAsset:Analysis|first_level_url:symbol|button:Title|lock_status:Archived|line:1









Message in reply to:

Seeking Alpha emailed IPIX update."Stocks on the move"

Innovation Pharma reports more "positive" COVID-related Brilacidin data
Jun. 17, 2020 12:58 PM ET|About: Innovation Pharmaceutical... (IPIX)|By: Vandana Singh, SA News Editor

Nano cap Innovation Pharmaceuticals (OTCQB:IPIX +28.3%) announces new results from ongoing laboratory tests evaluating Brilacidin's effects on the SARS-CoV-2 virus in cell cultures.

In a human lung epithelial cell line, Brilacidin reduced viral load by 95% and 97%, respectively, compared to control, at two therapeutic concentrations tested while being non-toxic to the cells.

The company says the new data reinforce previous testing, in VERO cells, where Brilacidin showed inhibition of 75% against SARS-CoV-2 compared to control.

Results, when completed, will be submitted for publication. Data generated to date supported a federal grant application filed last week by RBL, the testing laboratory, in collaboration with IPIX seeking funds to finance studies evaluating Brilacidin as a pan-coronavirus therapeutic.

It is in the process of manufacturing Brilacidin for intravenous dosing and will be seeking FDA guidance on a proposed COVID-19 clinical trial.

https://seekingalpha.com/news/3583879-innovation-pharma-reports-positive-covid-related-brilacidin-data?utm_medium=email&utm_source=seeking_alpha&mail_subject=ipix-innovation-pharma-reports-more-positive-covid-related-brilacidin-data&utm_campaign=rta-stock-news&utm_content=link-3